← Leaderboards
James D. Marks
University Of California San Francisco
$20,268,352
Attributed
$20,268,352
Total exposure
14
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.5M · FY2005–18$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$26,047,965 · 15
By mechanism
U01$8,879,628 · 2
P41$7,758,641 · 7
R01$5,448,316 · 1
U54$1,762,743 · 2
R33$1,336,571 · 1
R21$862,066 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Lenore Palma Pereira$9,175,126
Others in their field
Top investigators on “Antibodies”
- Lawrence Corey · Fred Hutchinson Cancer Center$525,765,536
- Bambra Strokes · Ppd Development Lp$461,655,950
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$385,009,925
- Barton F Haynes · Duke University$372,611,596
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$323,573,074
- Dennis R. Burton · Scripps Research Institute$306,733,901
Research focus
AntibodiesGenerationsMonoclonal AntibodiesSerotypingFundingIntensive CareBontoxilysinIn VivoYeastsBinding (Molecular Function)AffinityBotulismProductionBaseCell LineEpitopesAntitoxinsResearch PersonnelBioterrorismGenesPreventionRecombinantsBlood CirculationEngineering
Grant awards (47)
Antibody Research Technology Center$1,027,684
P41 · FY2018 · CA · contact PI
Renewable antibodies to secreted proteins and single and multi-pass cell surface$373,124
P41 · FY2018 · CA · contact PI
Antibody Research Technology Center$1,048,974
P41 · FY2017 · CA · contact PI
Generation of therapeutic antibodies to serotype F botulism$951,435
R01 · FY2017 · AI · contact PI
Renewable antibodies to secreted proteins and single and multi-pass cell surface$381,739
P41 · FY2017 · CA · contact PI
Antibody Research Technology Center$1,072,259
P41 · FY2016 · CA · contact PI
Generation of therapeutic antibodies to serotype F botulism$1,013,043
R01 · FY2016 · AI · contact PI
Trispecific monoclonal antibody for botulinum neurotoxin intoxication therapy$446,742
R33 · FY2016 · AI · contact PI
Renewable antibodies to secreted proteins and single and multi-pass cell surface$392,332
P41 · FY2016 · CA · contact PI
Generation of therapeutic antibodies to serotype F botulism$1,143,779
R01 · FY2015 · AI · contact PI
Antibody Research Technology Center$1,081,184
P41 · FY2015 · CA · contact PI
Trispecific monoclonal antibody for botulinum neurotoxin intoxication therapy$451,492
R33 · FY2015 · AI · contact PI
Renewable antibodies to secreted proteins and single and multi-pass cell surface$400,748
P41 · FY2015 · CA · contact PI
Antibody Research Technology Center$1,549,512
P41 · FY2014 · CA · contact PI
Generation of therapeutic antibodies to serotype F botulism$1,140,059
R01 · FY2014 · AI · contact PI
Trispecific monoclonal antibody for botulinum neurotoxin intoxication therapy$438,337
R33 · FY2014 · AI · contact PI
Renewable antibodies to secreted proteins and single and multi-pass cell surface$409,436
P41 · FY2014 · CA · contact PI
Generation of therapeutic antibodies to serotype F botulism$1,200,000
R01 · FY2013 · AI · contact PI
Evolving Diagnostic Antibodies for Botulinum Neurotoxins$273,482
U54 · FY2013 · AI · contact PI
Trispecific monoclonal antibody for botulinum neurotoxin intoxication therapy$201,009
R21 · FY2013 · AI · contact PI
Evolving Diagnostic Antibodies for Botulinum Neurotoxins$271,380
U54 · FY2012 · AI · contact PI
Trispecific monoclonal antibody for botulinum neurotoxin intoxication therapy$207,807
R21 · FY2012 · AI · contact PI
Development of botulinum neurotoxin immunotherapy, serotypes C, D, F, and G$86,962
U01 · FY2012 · AI · contact PI
Development of botulinum neurotoxin immunotherapy, serotypes C, D, F, and G$739,630
U01 · FY2011 · AI · contact PI
Evolving Diagnostic Antibodies for Botulinum Neurotoxins$307,710
U54 · FY2011 · AI · contact PI
USING MASS SPEC TO DETERMINE MOLECULAR IDENTITY OF TUMOR SPECIFIC ANTIGEN$33
P41 · FY2011 · RR · contact PI
Development of botulinum neurotoxin immunotherapy, serotypes C, D, F, and G$741,289
U01 · FY2010 · AI · contact PI
Design and Generation of Cross- Reactive Botulinum Neurotoxin Antibodies$296,494
U54 · FY2010 · AI · contact PI
USING MASS SPEC TO DETERMINE MOLECULAR IDENTITY OF TUMOR SPECIFIC ANTIGEN$1,766
P41 · FY2010 · RR · contact PI
Development of botulinum neurotoxin immunotherapy, serotypes C, D, F, and G$746,045
U01 · FY2009 · AI · contact PI
Design and Generation of Cross- Reactive Botulinum Neurotoxin Antibodies$297,133
U54 · FY2009 · AI · contact PI
USING MASS SPEC TO DETERMINE MOLECULAR IDENTITY OF TUMOR SPECIFIC ANTIGEN$11
P41 · FY2009 · RR · contact PI
Development of botulinum neurotoxin immunotherapy, serotypes C, D, F, and G$742,658
U01 · FY2008 · AI · contact PI
Development of botulinum neurotoxin immunotherapy$792,374
U01 · FY2007 · AI · contact PI
Development of botulinum neurotoxin immunotherapy, serotypes C, D, F, and G$729,744
U01 · FY2007 · AI · contact PI
Development of botulinum neurotoxin immunotherapy$1,145,202
U01 · FY2006 · AI · contact PI
PHAGE ANTIBODY BASED PROBES OF ERBB RECEPTOR FUNCTION$158,272
U54 · FY2006 · CA · contact PI
USING MASS SPEC TO DETERMINE MOLECULAR IDENTITY OF TUMOR SPECIFIC ANTIGEN$24
P41 · FY2006 · RR · contact PI
Development of botulinum neurotoxin immunotherapy$1,065,728
U01 · FY2005 · AI
USING MASS SPEC TO DETERMINE MOLECULAR IDENTITY OF TUMOR SPECIFIC ANTIGEN$3,417
P41 · FY2005 · RR
Development of botulinum neurotoxin immunotherapy$1,224,595
U01 · FY2004 · AI
USING MASS SPEC TO DETERMINE MOLECULAR IDENTITY OF TUMOR SPECIFIC ANTIGEN$16,398
P41 · FY2004 · RR
Development of botulinum neurotoxin immunotherapy$865,401
U01 · FY2003 · AI
Deciphering toxin neutralization by oligoclonal antibody$227,250
R21 · FY2003 · AI
Deciphering toxin neutralization by oligoclonal antibody$226,000
R21 · FY2002 · AI
PHAGE ANTIBODY BASED PROBES OF ERBB RECEPTOR FUNCTION$158,272
U54 · FY2002 · CA
PHAGE ANTIBODY BASED PROBES OF ERBB RECEPTOR FUNCTION$0
U54 · FY2001 · CA